Senior housing analysts report on rising SNF coronavirus cases … Paxlovid antiviral COVID-19 pill appears to be effective against omicron … Nearly half of American adults have gained weight during...
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
Clinical briefs for Thursday, Sept. 23
By
Alicia Lasek
Sep 23, 2021
CDC advisers predict decline in coronavirus cases and deaths this fall … Antidiabetic treatment requires improvements to lower hypoglycemia risk in elders … Study pinpoints unmet clinical care needs...
Clinical briefs for Friday, April 9
By
Alicia Lasek
Apr 09, 2021
Focus shifts to short-stay residents to prevent future COVID-19 outbreaks … U.S. COVID vaccination rates to plateau in April, survey results suggest … U.S. hits COVID shot target; 25% of adults now...
COVID-19 may be a new risk factor for chronic pain, national study finds
By
Alicia Lasek
Jun 30, 2023
Fully 26% of study participants with moderate to severe COVID-19 symptoms reported frequent pain, researchers report.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.